A detailed history of Pro Share Advisors LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 8,263 shares of PRCT stock, worth $773,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,263
Previous 5,665 45.86%
Holding current value
$773,416
Previous $346,000 91.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$56.31 - $84.99 $146,293 - $220,804
2,598 Added 45.86%
8,263 $661,000
Q2 2024

Aug 13, 2024

SELL
$45.73 - $69.19 $72,482 - $109,666
-1,585 Reduced 21.86%
5,665 $346,000
Q1 2024

May 08, 2024

BUY
$40.38 - $50.75 $23,016 - $28,927
570 Added 8.53%
7,250 $358,000
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $166,265 - $289,978
6,680 New
6,680 $279,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.